Associate Director- Sustainability & Impact (Lyon, France)
Archimed
Lyon, France · Onsite · Full Time
Posted
Job description
Location : Lyon, France About ARCHIMED: With offices in Europe, North America and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €8 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation. The Team • An international team (with more than 30 nationalities) with complementary education and experience in the investment, medical, scientific, strategic and operational sectors • Composed of alumni from: INSEAD, Berkeley, Georgetown, Bocconi, HEC Paris, Ponts et Chaussées, ESSEC, Imperial College, Dartmouth, etc. • Professional backgrounds: Private Equity (3i, Siparex, USS Ltd, Barings, capiton), Consulting (A.T. Kearney, Bain, McKinsey), M&A (Lazard, EY, KPMG, PwC), Industry (Biotronik, Cerba, Pharmacy, Veterinary) Your Role Portfolio engagement and value creation Lead portfolio engagement on Sustainability and Impact (S&I), providing hands-on support to portfolio companies and tracking S&I progress across ARCHIMED’s portfolios through dashboards, KPIs, and supporting processes. Lead select portfolio value creation projects, collaborating with deal teams as well as guiding and project managing S&I interns where required. Develop and oversee the execution of actionable S&I roadmaps for each portfolio company, with targets and milestones based on the company’s materiality analysis and aligned with ARCHIMED’s S&I strategy, partnering with third-party technical experts when necessary. Influence portfolio company management to advance their roadmaps through technical guidance and sharing of best practices. Investment process Act as the bridge between deal teams and external providers during due diligence, critically assessing findings to confirm that each target is consistent with ARCHIMED…